Human Growth and Development Fall 2018 Psy 213 R1 Test 1. Directions: Please answer all of the following questions. Each of your responses should be a few paragraphs long. Your paper is due on Wednesday, November 28th. . You may email your completed paper to me prior to the 28th at [email protected]. Should you choose the email option, I will respond to you via email. 1. Which perspective on human development is closet to your own and why? The perspectives are: psychoanalytic, learning, cognitive, evolutionary/sociobiological and contextual. 2. Provide an example of a critical period of childhood development and discuss of each of the domains of development: physical, cognitive, and psychosocial. In each of the domains give an example of change that is quantitative and an example that is qualitative. 3. In the future, if specific genes are identified as being associated with particular characteristic or traits such as obesity or sexual orientation, what possible outcomes would you predict in terms of increase or decrease in the amount or availability of genetic testing? What, if any, ethical issues do you think this may present? 4. In your opinion, what is the most interesting topic that we’ve covered in class or in your readings in the text book? Why? Please be specific. Canopy Crowth Competitive Analysis Canopy Growth Corporation is leader in the cannabis industry. However, it has also had its share of competitors, with a potential growth as Marijuana becomes legalized around the world. Today, Canopy’s largest competitors are Aurora Cannabis, located in Bristish Columbia,CA and Trulieve, located in FL,US. All three companies operate as a healthcare or consumer products industry and are licensed marijuana producers. Marketing Comparison Products: As the world’s largest legal cannabis distributor, Canopy Growth has an extensive variety of medicinal and recreational products to offer their consumers. Tweed, the company’s original brand, is recognized world-wide. In addition to cannabis, they are well known for their CBD soft gels. As previously stated, the company has been ambitious from the beginning. Since it’s inception, numerous additional brands operate under the Canopy umbrella. Brands like DNA Genetics and CraftGrow are dedicated to innovation in cannabis market. Conversely, Spectrum Therapeutics is Canopy’s world-wide medicinal brand focused on patient education and the simplification of purchasing medicinal cannabis products. (14) Aurora Cannabis, Canopy’s rival in Canada, is a cannabis company that focuses their endeavors on supplying medicinal products. Pricing: Placement: Promotion: Current Business-Level Strategy (Jonathan) (low providers?differentiators?how? Focus or niche players? What segment?) Financial Comparison Sales: Canopy continues to take the lead with 10,102 kilograms of marijuana sales, approximately four times the amount sold a year back. Their ...

1. Human Growth and Development
Fall 2018
Psy 213 R1
Test 1.
Directions: Please answer all of the following questions. Each
of your responses should be a few paragraphs long. Your paper
is due on Wednesday, November 28th. . You may email your
completed paper to me prior to the 28th at [email protected].
Should you choose the email option, I will respond to you via
email.
1. Which perspective on human development is closet to your
own and why? The perspectives are: psychoanalytic, learning,
cognitive, evolutionary/sociobiological and contextual.
2. Provide an example of a critical period of childhood
development and discuss of each of the domains of
development: physical, cognitive, and psychosocial. In each of
the domains give an example of change that is quantitative and
an example that is qualitative.
3. In the future, if specific genes are identified as being
associated with particular characteristic or traits such as obesity
or sexual orientation, what possible outcomes would you predict
in terms of increase or decrease in the amount or availability of
genetic testing? What, if any, ethical issues do you think this
may present?
4. In your opinion, what is the most interesting topic that we’ve
covered in class or in your readings in the text book? Why?

2. Please be specific.
Canopy Crowth Competitive Analysis
Canopy Growth Corporation is leader in the cannabis industry.
However, it has also had
its share of competitors, with a potential growth as Marijuana
becomes legalized around the
world. Today, Canopy’s largest competitors are Aurora
Cannabis, located in Bristish
Columbia,CA and Trulieve, located in FL,US. All three
companies operate as a healthcare or
consumer products industry and are licensed marijuana
producers.
Marketing Comparison
Products:
As the world’s largest legal cannabis distributor, Canopy
Growth has an extensive variety
of medicinal and recreational products to offer their consumers.
Tweed, the company’s original
brand, is recognized world-wide. In addition to cannabis, they
are well known for their CBD soft
gels. As previously stated, the company has been ambitious
from the beginning. Since it’s

3. inception, numerous additional brands operate under the Canopy
umbrella. Brands like DNA
Genetics and CraftGrow are dedicated to innovation in cannabis
market. Conversely, Spectrum
Therapeutics is Canopy’s world-wide medicinal brand focused
on patient education and the
simplification of purchasing medicinal cannabis products. (14)
Aurora Cannabis, Canopy’s rival in Canada, is a cannabis
company that focuses their
endeavors on supplying medicinal products.
Pricing:
Placement:
Promotion:
Current Business-Level Strategy (Jonathan)
(low providers?differentiators?how? Focus or niche players?
What segment?)
Financial Comparison
Sales:
Canopy continues to take the lead with 10,102 kilograms of

4. marijuana sales,
approximately four times the amount sold a year back. Their
growth continues to exceed with
stock prices over two times it’s competitors in the NYSE,
Canopy Growth takes the lead with
$20.45USD. Aurora’s listed as $3.70 and Trulieve as $10.14.
Additionally, Canopy Growth
Corporation has seen a net revenue of C$90.47M recently.(1)
Ending year June 2019, Aurora
has produced net revenue of C$247.9M, nearly $187.35M USD,
whilst Trulieve has seen
$57.9M, approximately C$75.8M, despite it’s earlier year
projections of $214M. The sales for
Aurora have surged to 349% increase and a production increase
of 920%.(2) Canopy has had a
yearly sales growth of 249% while Trulieve trailed back with a
130% increase in growth. For the
quarter as Aurora increased by 61%, Canopy saw a drop to -
4%.(3)
Profit:
However, Canopy’s high costs continue to rise along with all

5. their growth approximately
at a slightly faster rate. Canopy has seen a quick rise in costs in
just a year alone including
C$9.4M marketing costs that increased to C$44.9M and
C$11.1M in administrative costs which
increased to C$46.1M.(4) Due to Canopy’s increasingly high
costs, they are currently seeing no
profits, instead a hefty loss of C$-1,281,168,000, similarly to
Aurora.(5) The costs are being
significantly impacted by its production needs in property plant
and equipment, specifically,
assets in process, buildings, greenhouses, production and
warehouse equipment as well as costs
of subsidiary acquisitions. Additionally some other high
intangible costs are affecting the bottom
line significantly including operating licenses and intellectual
property costs. The investor
confidence is not high for Canopy Growth, nevertheless,
investors counter options are trailing
too far behind. With Canopy’s biggest competitor Aurora
selling only 6,999 kilos of marijuana.
Production capabilities in this sector have become increasingly
important as legalization opens
up consumer demand globally.

6. Aurora Cannabis has seen a total net revenue of C$247,939,000
and a net loss of
C$-290,837,000.(6) On the other hand Trulieve has seen a total
revenue of $57,920,112 and a net
income of $57,528,785. (7) Trulieve has been operating with a
total profit as opposed to a loss
like Aurora and Canopy. Although Trulieve has not seen a
bigger loss than top two Canadian
cannabis companies, Aurora and Canopy, this does not put
Trulieve at an advantage. it’s
production capabilities and innovation has been far less, with no
investments in Research and
Development compared to Canopy’s C$8,474,000 and Aurora’s
C$14,778,000 investment.
Market Share:
Aurora is valued at…, while Cronos and Tilray are valued at
5.8B and 3.5B respectively.
However, Canopy Growth is a clear leader with a 12.1B
valuation. Aurora and Canopy are neck
to neck in competition. Both seem to perform similarly with
large revenues and increasing

7. production costs, their growth as well as their trajectories seem
to be almost synced. As of
October 2019 Canopy’s recent fall to second place in this
quarter may be due to the departure of
CEO, Bruce Linton. On the other hand Trulieve may be seeing
the effects of states still not
legalizing marijuana for medical or recreational use. All
industries face some form of scare with
issues such as Vape health concerns currently arising. This is a
hurdle for all companies globally,
but is heavily being seen in the US for Trulieve. These concerns
could possibly be causing the
stunt in growth for many cannabis selling companies in the US,
compared to the massive growth
for Canadian companies.
(8)
Although there doesn’t seem to be sufficient information in the
share of the market by
each company, due to the mass amount of acquisitions
happening frequently and the novelty in
this industry, we discovered that Aurora has a market share of

8. 20% in Canada. (9) Increased
competition has led to a difficulty in companies penetrating the
market and remaining strong,
lasting in this industry. It has also created a ban on inter-state
trading across the US, which is a
big concern for companies. (10) Nevertheless, there is a
discussion of the market share of
cannabis by product type. Most sales seem to be in the form of
Buds. This is due to the use for
smoking and affordability. However due to the unknown level
of consumption of CBD and THC
within buds, oils seem to be expected to grow faster. A market
that was predominantly used for
medical purposes, now sees a leveled market share with
cannabis as a recreational use. In 2025,
the use of cannabis recreationally is expected to surpass
cannabis for medical use.
(10)
(10)

9. Comprehensively, consumer confidence seems to be growing as
pot stocks continue to
rise in the market. The growth of marijuana demand is said to
increase as recreational marijuana
becomes legalized. However, this will be a battle of whose
production can keep up with an
expected growth in demand and so far, Canopy seems to be
advantageous in this aspect.
Value Chain Analysis
Canopy growth is North America’s lead producer of marijuana
that is legal. It was
formerly known as Tweed Marijuana Inc. And has become
famous for its rapid growth over the
years since its inception in 2013 by Chuck Rifici, Mark Zekulin
and Bruce Linton. The main aim
for its formation was to provide patients with affordable
medicinal Marijuana.
Value chain analysis refer to the process in which a firm
identifies its support and
primary activities and focuses on value addition of the final
product and the analysis of these
activities, therefore resulting in reduced cost or increased

10. differentiation of products. Potus value
chain model highlights the need to enhance primary activities
such as; inbound logistics,
operations, outbound logistics, sales and marketing and service,
and support activities such as
firm infrastructure, procurement, human resource management
and technology, so as to gain
profit in the long run.
From Canopy growth, we see that Canopy Growth was majorly
founded with an
objective of providing Cannabis patients with affordable
medicine. They adopted a concept
known as Compassionate Pricing, which has since become a
standard worldwide, and has
become something for other companies to bench mark. This
concept in the long run encourages
more sales for Canopy compared to competitors, thus yielding
higher profits. Another useful tool
for Canopy is the application of technology, in this case
biotechnology. This goes a long way in
improving its products and services, hence attracting more
customers and yielding more profits.
Also the fact that Canopy works with numerous brands, means
more diversification of products

11. and more profit, compared to other firms.
Over the years, Canopy has also managed to attract a lot of
sales, with 2018 recording the
highest revenues of $ 77.9, showing it is making profit relative
to other companies. The fact that
it was the first company in the Toronto stock exchange, and
later the first company at New York
stock exchange shows that these occurrences make it a pioneer,
hence Canopy growth has had a
large uncompleted opportunity to seek for investors, expand its
operations and yield more profit.
Assessment
(Understanding of primary competitors? Business strategies?
Strength and weaknesses?)

12. References
1. https://www.newcannabisventures.com/stock-cgc-twmjf-
canopy-growth-corp
2. https://www.ibtimes.com/marijuana-stock-aurora-cannabis-
posts-349-sales-growth-launc
hes-new-products-year-2827347
3. https://www.newcannabisventures.com/cannabis-company-
revenue-ranking/
https://www.newcannabisventures.com/stock-cgc-twmjf-canopy-
growth-corp/
https://www.ibtimes.com/marijuana-stock-aurora-cannabis-
posts-349-sales-growth-launches-new-products-year-2827347
https://www.ibtimes.com/marijuana-stock-aurora-cannabis-
posts-349-sales-growth-launches-new-products-year-2827347
https://www.newcannabisventures.com/cannabis-company-
revenue-ranking/
4. https://www.marketwatch.com/story/canopy-growth-shows-
surging-pot-sales-in-late-arri
ving-earnings-report-2019-02-14
5. https://www.canopygrowth.com/wp-
content/uploads/2019/08/Q1-FY2020-Financial-Stat
ements-Final.pdf

13. 6. https://finance.yahoo.com/quote/ACB/financials?p=ACB
7. https://investors.trulieve.com/static-files/e3092d0d-5d97-
4d2b-be72-c1e53c24a9d2
8. https://disa.com/map-of-marijuana-legality-by-statel
9. https://www.marketwatch.com/story/aurora-cannabis-
earnings-show-big-growth-in-pot-s
ales-but-worrisome-profit-trend-2019-02-11
10. https://www.grandviewresearch.com/industry-analysis/us-
cannabis-market
11. https://craft.co/canopy-
growth/competitors?competitors=canopy-growth%2Corganigram
%2Ctts-pharma%2Ctilray%2Ccronos-group%2Caurora-cannabis
12. https://seekingalpha.com/article/4224627-canopy-growth-
cannabis-market-leader
13. https://www.fastcompany.com/90285740/how-canopy-
growth-became-the-jolly-green-gi
ant-of-cannabis
14. https://www.canopygrowth.com/brands/
15.
https://www.marketwatch.com/story/canopy-growth-shows-
surging-pot-sales-in-late-arriving-earnings-report-2019-02-14
https://www.marketwatch.com/story/canopy-growth-shows-
surging-pot-sales-in-late-arriving-earnings-report-2019-02-14

14. https://www.canopygrowth.com/wp-
content/uploads/2019/08/Q1-FY2020-Financial-Statements-
Final.pdf
https://www.canopygrowth.com/wp-
content/uploads/2019/08/Q1-FY2020-Financial-Statements-
Final.pdf
https://finance.yahoo.com/quote/ACB/financials?p=ACB
https://investors.trulieve.com/static-files/e3092d0d-5d97-4d2b-
be72-c1e53c24a9d2
https://disa.com/map-of-marijuana-legality-by-state
https://www.marketwatch.com/story/aurora-cannabis-earnings-
show-big-growth-in-pot-sales-but-worrisome-profit-trend-2019-
02-11
https://www.marketwatch.com/story/aurora-cannabis-earnings-
show-big-growth-in-pot-sales-but-worrisome-profit-trend-2019-
02-11
https://www.grandviewresearch.com/industry-analysis/us-
cannabis-market
https://craft.co/canopy-
growth/competitors?competitors=canopy-
growth%2Corganigram%2Ctts-pharma%2Ctilray%2Ccronos-
group%2Caurora-cannabis
https://craft.co/canopy-
growth/competitors?competitors=canopy-
growth%2Corganigram%2Ctts-pharma%2Ctilray%2Ccronos-
group%2Caurora-cannabis
https://seekingalpha.com/article/4224627-canopy-growth-
cannabis-market-leader
https://www.fastcompany.com/90285740/how-canopy-growth-
became-the-jolly-green-giant-of-cannabis
https://www.fastcompany.com/90285740/how-canopy-growth-
became-the-jolly-green-giant-of-cannabis
https://www.canopygrowth.com/brands/
Running head; Canopy Growth Value Chain Analysis

15. 1
Canopy Growth Value Chain Analysis
2
Canopy Growth Value Chain Analysis
Name
Institutional affairs
Date
Canopy Growth Value Chain
Analysis
Canopy growth is North America’s lead producer of marijuana
that is legal. It was formerly known as Tweed Marijuana Inc.
And has become famous for its rapid growth over the years
since its inception in 2013 by Chuck Rifici, Mark Zekulin and
Bruce Linton. The main aim for its formation was to provide
patients with affordable medicinal Marijuana.
Value chain analysis refer to the process in which a firm
identifies its support and primary activities and focuses on
value addition of the final product and the analysis of these
activities, therefore resulting in reduced cost or increased
differentiation of products. Potus value chain model highlights
the need to enhance primary activities such as; inbound
logistics, operations, outbound logistics, sales and marketing
and service, and support activities such as firm infrastructure,
procurement, human resource management and technology, so
as to gain profit in the long run.

16. From Canopy growth, we see that Canopy Growth was majorly
founded with an objective of providing Cannabis patients with
affordable medicine. They adopted a concept known as
Compassionate Pricing, which has since become a standard
worldwide, and has become something for other companies to
bench mark. This concept in the long run encourages more sales
for Canopy compared to competitors, thus yielding higher
profits. Another useful tool for Canopy is the application of
technology, in this case biotechnology. This goes a long way in
improving its products and services, hence attracting more
customers and yielding more profits. Also the fact that Canopy
works with numerous brands, means more diversification of
products and more profit, compared to other firms.
Over the years, Canopy has also managed to attract a lot of
sales, with 2018 recording the highest revenues of $ 77.9,
showing it is making profit relative to other companies. The
fact that it was the first company in the Toronto stock exchange,
and later the first company at New York stock exchange shows
that these occurrences make it a pioneer, hence Canopy growth
has had a large uncompleted opportunity to seek for investors,
expand its operations and yield more profit.
References
Grant, R.M. (2010). Contemporary Strategy Analysis. 7th ed.
John Wiley & Sons, p. 239-241
Canopy Growth Corporation. Retrieved from
www.canopygrowth.com Freeman, S. (2016).
Canopy Growth Corporation to acquire Mettrum for $430 M-
making a mega-company serving half Canada’s medical pot
users. Retrieved June 28, 2017
Kristine Owram (2019). Canopy Analysis. Retrieved from;

17. https://www.bloomberg.com/news/articles/2019-08-15/canopy-
shares-tumble-as-a
Nalysts-surprised-by-declining-revenue
Paul Monica (2019).Canopy’s cannabis business growth.
Retrieved from
https://edition.cnn.com/2019/02/15/investing/canopy-growth-
cannabis-earnings/in dex.html
Susan Berfield (2019). Canopy’s Bruce Linton. Retrieved from
https://www.bloomberg.com/features/2019-canopy-cannabis-
bruce-linton-canadaWeed
Canopy Growth. (2019, September 11). Retrieved from
https://en.wikipedia.org/wiki/Canopy_Growth
Our Story. (n.d.). Retrieved from
https://www.tweed.com/en/our-story
Marijuana Company heads to New York Stock Exchange. (2018,
October 25).Retrieved from https://wtop.com/business-
finance/2018/10/marijuana-company-heads-to-new-yor K-stock-
exchange/